Stock Information
Stoke Therapeutics Inc (STOK)
Ticker Symbol: STOK
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,870.02 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -0.1346
Revenue (TTM): $3.11 M
Dividend Yield: N/A%
ROE: -2.05%
Latest News
-
Stoke Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4)
Thu, Apr 16, 2026 4:45 PM
-
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Tue, Apr 14, 2026 2:00 PM
Key Financials
Financial data not available